Rita Mukhtar, MD, breast oncologic surgeon, affiliate professor of surgical procedure, Division of Surgical Oncology, Lobular Breast Most cancers Program, College of California,...
On this video, Kelly L. Stratton, MD, FACS, discusses a noteworthy side of a section 1B trial evaluating relugolix (Orgovyx) and enzalutamide (Xtandi)...